Chordate Medical’s CEO to BioStock: “We are building step by step”

Chordate’s Q1 report shows higher sales and a reduced operating loss compared to the same period last year. The company has also focused on increasing awareness of the migraine treatment Ozilia among investors and the life science industry at various conferences. BioStock contacted CEO Anders Weilandt to find out more.

Read the full article at biostock.se:

https://www.biostock.se/en/2024/05/chordate-medicals-ceo-we-are-building-step-by-step/

This is a press release from BioStock - Connecting Innovation & Capital. https://www.biostock.se